Skip to main content
. 2021 May 31;9(1):e002203. doi: 10.1136/bmjdrc-2021-002203

Table 3.

Glycemic characteristics and outcomes in patients with DM and COVID-19

Glycemic characteristics ICU care, unadjusted,
OR (95% CI)
ICU care,
adjusted*
Ventilator, unadjusted Ventilator,
adjusted
Mortality,
unadjusted
Mortality,
adjusted
Outpatient insulin use (n=111) 1.08 (0.51 to 2.29) 0.98 (0.44 to 2.12) 1.76 (0.78 to 4.0) 1.71 (0.71 to 4.1) 0.77 (0.18 to 3.4) 0.71 (0.16 to 3.2)
Hemoglobin A1c (n=92) 1.07 (0.89 to 1.27) 1.02 (0.85 to 1.24) 1.15 (0.95 to 1.38) 1.11 (0.92 to 1.36) 1.00 (0.7 to 1.43) 0.97 (0.67 to 1.42)
Glucose on admission† (n=110) 1.02 (0.98 to 1.06) 1.02 (0.98 to 1.06) 1.03 (0.99 to 1.07) 1.03 (0.99 to 1.08) 1.02 (0.96 to 1.08) 1.02 (0.96 to 1.09)
Mean glucose per patient-day† (n=96) 0.95 (0.85 to 1.05) 0.91 (0.82 to 1.02) 0.93 (0.83 to 1.04) 0.88 (0.78 to 1.01) 0.86 (0.69 to 1.07) 0.82 (0.64 to 1.05)

*Each characteristic was adjusted for gender and age.

†OR calculated per every 10 mg/dL of glucose.

DM, diabetes mellitus; ICU, intensive care unit.